Perrigo | PRGO - Current Assets


Perrigo reported $2.8B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Abbott USD 26B 1.16B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Dr.Reddys Laboratories INR 297.55B 18.03B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Merck USD 47.56B 10.49B Sep/2025
Nestle CHF 31.97B 1.46B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi EUR 30.16B 789M Mar/2026
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025
Zoetis USD 6.77B 185M Dec/2025